Advocacy for mushroom Vape Lions Mane part three

1. World Health Organization Depression 2018. [(accessed on 10 July 2019)]; Available online: https://www.who.int/news-room/fact-sheets/detail/depression
2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Bartolomucci A., Leopardi R. Stress and depression: Preclinical research and clinical implications. PLoS ONE. 2009;4:e4265. doi: 10.1371/journal.pone.0004265. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Kanter J.W., Busch A.M., Weeks C.E., Landes S.J. The nature of clinical depression: Symptoms, syndromes, and behavior analysis. Behav. Anal. 2008;31:1–21. doi: 10.1007/BF03392158. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. McMahon F.J., Buervenich S., Charney D., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J.M., Papanicolaou G.J., Laje G., Fava M., et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am. J. Hum. Genet. 2006;78:804–814. doi: 10.1086/503820. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Hillhouse T.M., Porter J.H. A brief history of the development of antidepressant drugs: From monoamines to glutamate. Exp. Clin. Psychopharmacol. 2015;23:1–21. doi: 10.1037/a0038550. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Santarsieri D., Schwartz T.L. Antidepressant efficacy and side-effect burden: A quick guide for clinicians. Drugs Context. 2015;4:1–12. doi: 10.7573/dic.212290. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. InformedHealth.org . Depression: How Effective are Antidepressants? Institute for Quality and Efficiency in Health Care (IQWiG); Cologne, Germany: 2015. [Google Scholar]
9. Thase M.E. Introduction: Defining remission in patients treated with antidepressants. J. Clin. Psychiatry. 1999;60:3–6. [PubMed] [Google Scholar]
10. Ashton A.K., Jamerson B.D., Weinstein W.L., Wagoner C. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey. Curr. Ther. Res. 2005;66:96–106. doi: 10.1016/j.curtheres.2005.04.006. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Hodgson K., Tansey K.E., Uher R., Dernovšek M.Z., Mors O., Hauser J., Souery D., Maier W., Henigsberg N., Rietschel M., et al. Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology. 2015;232:2609–2617. doi: 10.1007/s00213-015-3898-x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Rheker J., Winkler A., Doering B.K., Rief W. Learning to experience side effects after antidepressant intake—Results from a randomized, controlled, double-blind study. Psychopharmacology. 2017;234:329–338. doi: 10.1007/s00213-016-4466-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Phan C.W., David P., Naidu M., Wong K.H., Sabaratnam V. Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: Diversity, metabolite, and mechanism. Crit. Rev. Biotechnol. 2015;35:355–368. doi: 10.3109/07388551.2014.887649. [PubMed] [CrossRef] [Google Scholar]
14. Chan Y.C., Chen C.C., Lee L.Y., Chen W.P. Active Substances for Preventing Hearing Deterioration, the Composition Containing the Active Substances, and the Preparation Method Thereof. 10,405,504. U.S. Patent. 2019 Sep 10;
15. Qureshi N.A., Al-Bedah A.M. Mood disorders and complementary and alternative medicine: A literature review. Neuropsychiatr. Dis. Treat. 2013;9:639–658. doi: 10.2147/NDT.S43419. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Pan S.Y., Zhou S.F., Gao S.H., Yu Z.L., Zhang S.F., Tang M.-K., Sun J.N., Ma D.L., Han Y.F., Fong W.-F., et al. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evid.-Based Complement. Altern. Med. 2013;2013:627375. doi: 10.1155/2013/627375. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
17. Thongbai B., Rapior S., Hyde K.D., Wittstein K., Stadler M. Hericium erinaceus, an amazing medicinal mushroom. Mycol. Prog. 2015;14:91. doi: 10.1007/s11557-015-1105-4. [CrossRef] [Google Scholar]
18. Lu Q.Q., Tian J.M., Wei J., Gao J.M. Bioactive metabolites from the mycelia of the basidiomycete Hericium erinaceum. Nat. Prod. Res. 2014;28:1288–1292. doi: 10.1080/14786419.2014.898145. [PubMed] [CrossRef] [Google Scholar]
19. Zhang C.C., Yin X., Cao C.Y., Wei J., Zhang Q., Gao J.M. Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells. Bioorg. Med. Chem. Lett. 2015;25:5078–5082. doi: 10.1016/j.bmcl.2015.10.016. [PubMed] [CrossRef] [Google Scholar]
20. Rahman M.A., Abdullah N., Aminudin N. Inhibitory effect on in vitro LDL oxidation and HMG Co-A reductase activity of the liquid-liquid partitioned fractions of Hericium erinaceus (Bull.) Persoon (Lion’s mane mushroom) BioMed Res. Int. 2014;2014:828149. doi: 10.1155/2014/828149. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Yi Z., Shao-Long Y., Ai-Hong W., Zhi-Chun S., Ya-Fen Z., Ye-Ting X., Yu-Ling H. Protective effect of ethanol extracts of Hericium erinaceus on alloxan-induced diabetic neuropathic pain in rats. Evid.-Based Complement. Altern. Med. 2015;2015:595480. doi: 10.1155/2015/595480. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Wang J.C., Hu S.H., Su C.H., Lee T.M. Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp. Kaohsiung J. Med Sci. 2001;17:461–467. [PubMed] [Google Scholar]
23. Zhang Z., Liu R.N., Tang Q.J., Zhang J.S., Yang Y., Shang X.D. A new diterpene from the fungal mycelia of Hericium erinaceus. Phytochem. Lett. 2015;11:151–156. doi: 10.1016/j.phytol.2014.12.011. [CrossRef] [Google Scholar]
24. Mori K., Ouchi K., Hirasawa N. The anti-inflammatory effects of lion’s mane culinary-medicinal mushroom, Hericium erinaceus (higher basidiomycetes) in a coculture system of 3T3-L1 adipocytes and RAW264 macrophages. Int. J. Med. Mushrooms. 2015;17:609–618. doi: 10.1615/IntJMedMushrooms.v17.i7.10. [PubMed] [CrossRef] [Google Scholar]
25. Liang B., Guo Z., Xie F., Zhao A. Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats. BMC Complement. Altern. Med. 2013;13:253. doi: 10.1186/1472-6882-13-253. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
26. Yang B.K., Park J.B., Song C.H. Hypolipidemic effect of an exo-biopolymer produced from a submerged mycelial culture of Hericium erinaceus. Biosci. Biotechnol. Biochem. 2003;67:1292–1298. doi: 10.1271/bbb.67.1292. [PubMed] [CrossRef] [Google Scholar]
27. Mori K., Inatomi S., Ouchi K., Azumi Y., Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial. Phytother. Res. 2009;23:367–372. doi: 10.1002/ptr.2634. [PubMed] [CrossRef] [Google Scholar]
28. Tsai-Teng T., Chin-Chu C., Li-Ya L., Wan-Ping C., Chung-Kuang L., Chien-Chang S., Chi-Ying H.F., Chien-Chih C., Shiao Y.J. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice. J. Biomed. Sci. 2016;23:49. doi: 10.1186/s12929-016-0266-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
29. Kuo H.C., Lu C.C., Shen C.H., Tung S.Y., Hsieh M.C., Lee K.C., Lee L.Y., Chen C.C., Teng C.C., Huang W.S., et al. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. J. Transl. Med. 2016;14:78. doi: 10.1186/s12967-016-0831-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar] Retracted
30. Lee K.F., Chen J.H., Teng C.C., Shen C.H., Hsieh M.C., Lu C.C., Lee K.C., Lee L.Y., Chen W.P., Chen C.C., et al. Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine. Int. J. Mol. Sci. 2014;15:15073–15089. doi: 10.3390/ijms150915073. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
31. Chiu C.H., Chyau C.C., Chen C.C., Lee L.Y., Chen W.P., Liu J.L., Lin W.H., Mong M.C. Erinacine A-enriched Hericium erinaceus mycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice. Int. J. Mol. Sci. 2018;19:341. doi: 10.3390/ijms19020341. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
32. Ryu S., Kim H.G., Kim J.Y., Kim S.Y., Cho K.O. Hericium erinaceus extract reduces anxiety and depressive behaviors by promoting hippocampal neurogenesis in the adult mouse brain. J. Med. Food. 2018;21:174–180. doi: 10.1089/jmf.2017.4006. [PubMed] [CrossRef] [Google Scholar]
33. Yao W., Zhang J.-C., Dong C., Zhuang C., Hirota S., Inanaga K., Hashimoto K. Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacol. Biochem. Behav. 2015;136:7–12. doi: 10.1016/j.pbb.2015.06.012. [PubMed] [CrossRef] [Google Scholar]
34. Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialog. Clin. Neurosci. 2002;4:7–20. [PMC free article] [PubMed] [Google Scholar]
35. Coppen A. The biochemistry of affective disorders. Br. J. Psychiatry. 1967;113:1237–1264. doi: 10.1192/bjp.113.504.1237. [PubMed] [CrossRef] [Google Scholar]

And 65 more